Fact-checked by Grok 2 weeks ago

Cavernous sinus

The cavernous sinus is a paired dural venous situated bilaterally at the , adjacent to the , and extending from the anteriorly to the petrous apex posteriorly, measuring approximately 2 cm in length and 1 cm in width. It consists of a network of interconnected venous channels trabeculated by arachnoid trabeculae, enclosing the cavernous segment of the and the (cranial nerve VI), while the lateral walls contain the oculomotor (III), trochlear (IV), and ophthalmic (V1) and maxillary () divisions of the trigeminal nerves, along with sympathetic fibers. This structure functions primarily as a venous conduit, receiving blood from the superior and inferior ophthalmic veins, the superficial middle cerebral vein, the sphenoparietal sinus, and other tributaries such as , meningeal, and pituitary , before draining into the superior and inferior petrosal es and ultimately the . The intercavernous es connect the two cavernous sinuses across the midline, facilitating bidirectional flow, while link it to the , allowing potential spread of infections from the face or . Embryologically, it forms from coalescing venous canals around the 27th week of , with physiologic variants including the laterocavernous sinus in about 24% of individuals, which can alter drainage patterns. Clinically, the cavernous sinus is significant due to its proximity to vital neurovascular structures, predisposing it to pathologies such as —often from facial or sinus infections spreading via valveless veins—aneurysms of the , or tumors like meningiomas and pituitary adenomas that can compress encased nerves, leading to cavernous sinus syndrome characterized by ophthalmoplegia, ptosis, proptosis, and sensory deficits. Surgical approaches, such as transsphenoidal or transorbital routes, must navigate its complex to avoid hemorrhage or nerve damage, with endovascular interventions for conditions like carotid-cavernous fistulas relying on precise mapping of its venous tributaries.

Anatomy

Location and Boundaries

The cavernous sinuses are paired dural venous structures located at the , positioned laterally to the and the body of the , forming a symmetric pair on either side of the . They extend anteriorly from the to the petrous apex posteriorly, spanning approximately 2 cm in length and 1 cm in height or width. This positioning places them within the middle cranial fossa, at the junction of the anterior and middle cranial fossae, the sphenoid wing, and the petroclival ridge. The roof of each cavernous sinus is formed by the meningeal layer of the dura mater, which extends from the anterior and middle cranial fossae and attaches to the anterior and middle clinoid processes anteriorly, becoming continuous with the diaphragma sellae medially and the tentorium cerebelli posteriorly. The floor consists of the endosteal or periosteal layer of dura overlying the greater wing of the sphenoid bone anteriorly and extending posteriorly along the clivus. Laterally, the wall is composed of a double layer of dura mater that covers the temporal lobe superiorly and Meckel's cave (housing the trigeminal ganglion) inferiorly. Medially, the wall is defined by the periosteal dura adjacent to the within the , with the paired intercavernous sinuses bridging the two cavernous sinuses anterior and posterior to the , facilitating communication across the midline. These sinuses lie in close proximity to midline structures, including the pituitary fossa inferiorly and the superiorly, underscoring their strategic position in the suprasellar region. Cranial nerves traverse the lateral wall and traverse the sinus itself en route to their destinations.

Internal Structure and Histology

The cavernous sinus is composed of a network of thin-walled venous channels separated by delicate trabeculae, forming an irregular plexus within the dural layers at the , and these channels lack valves, permitting bidirectional flow. This structure arises between two distinct layers of the : the outer periosteal (endosteal) layer, which forms the lateral wall, floor, and medial wall, and the inner meningeal (dura propria) layer, which contributes to the roof and upper medial wall. Histologically, the venous spaces are lined by a single layer of , supported by surrounding and fibrous septa that constitute the trabeculae, with occasional adipose elements interspersed in over 90% of cases. The walls of these channels contain no , rendering the sinus susceptible to distension under pressure changes. Variations in trabeculation density are common, with approximately 18% of sinuses exhibiting dense trabeculae, 64% showing moderate inferior medial trabeculations, and 18% displaying sparse formations, which collectively contribute to the characteristic "cavernous" appearance observed on imaging modalities such as MRI. These differences in internal can influence the sinus's and overall .

Contents

The cavernous sinus contains several cranial nerves that traverse its structure, along with sympathetic fibers, but no sensory ganglia. The primary neural elements include the oculomotor nerve (cranial nerve III), trochlear nerve (cranial nerve IV), abducens nerve (cranial nerve VI), and the ophthalmic (V1) and maxillary (V2) divisions of the trigeminal nerve (cranial nerve V). The oculomotor (III) and trochlear (IV) nerves are positioned superiorly within the sinus, embedded in the lateral wall between the inner endothelial layer and the outer dural layer. In contrast, the ophthalmic (V1) division runs horizontally in the lateral wall inferior to III and IV, while the maxillary (V2) division occupies the inferolateral portion of the lateral wall. The abducens nerve (VI) is uniquely located inferolaterally, floating freely within the sinus lumen amid the venous blood, rather than being fixed to the walls. Postganglionic sympathetic fibers from the carotid plexus travel along the sinus walls, often accompanying the or the without forming distinct bundles. No sensory ganglia reside within the sinus itself; for instance, the is located adjacent in Meckel's cave, posterior to the sinus. The spatial arrangement of these elements— with multiple nerves closely packed in the thin lateral dural folds and exposed in the central —creates a confined environment that predisposes the structures to from adjacent expansions.

Vascular Connections

The (ICA) traverses the cavernous sinus, forming a characteristic loop within the sinus. The ICA enters the cavernous sinus through the carotid sulcus after passing the , travels horizontally in its posterior portion, bends superiorly at the posterior genu, ascends vertically in the anterior portion, and exits superiorly through the proximal supraclinoid segment. A key branch arising from the posterior genu of the cavernous ICA is the meningohypophyseal trunk, which supplies the and . This trunk typically divides into three main branches: the inferior hypophyseal artery, which vascularizes the and ; the dorsal meningeal artery (or medial clival artery), which supplies the upper clivus and ; and the tentorial artery (or artery of Bernasconi-Cassinari), which provides blood to the tentorium cerebelli and adjacent dura. Venous inflow to the cavernous sinus occurs through multiple tributaries that converge into its lateral walls. The drains the and enters the anterior aspect of the via the , often connecting indirectly to the facial vein through the angular vein. The inferior ophthalmic vein similarly contributes orbital drainage, with one branch joining the cavernous posteriorly and the other potentially diverting to the . Additional inflows include the sphenoparietal , which collects from meningeal veins along the sphenoid wing and empties laterally into the , and the superficial middle cerebral vein, which drains the and joins either directly or via the sphenoparietal . Venous outflow from the cavernous sinus is directed posteriorly, inferiorly, and laterally through several channels. The superior petrosal sinus emerges from the posterior aspect of the sinus, coursing along the petrous apex to join the . The drains the posteroinferior portion, traveling along the clivus to connect with the jugular bulb or . Inferiorly, connections exist to the basilar plexus, a network of veins along the clivus that links the two cavernous sinuses and the es. Laterally, pass through foramina such as the foramen ovale to the , providing an extracranial drainage route. The left and right cavernous sinuses are interconnected by intercavernous sinuses, which traverse the midline anterior and posterior to the . These anterior and posterior intercavernous channels form a venous ring around the , facilitating cross-communication between the bilateral sinuses.

Function

Venous Drainage

The cavernous sinus serves as a critical venous conduit, primarily functioning to drain blood from the , anterior cerebral hemispheres, and nasopharynx. Venous blood from the enters via the superior and inferior ophthalmic veins, which collect from structures such as the ethmoidal veins, vorticose veins, central vein, , eyelids, and orbital muscles. From the anterior cerebral hemispheres, drainage occurs through the sphenoparietal sinus and superficial middle cerebral vein, which gather blood from the and adjacent cortical regions. Additionally, connect the nasopharynx to the cavernous sinus via the pterygoid plexus, facilitating drainage from pharyngeal and facial structures. Blood flow within the cavernous sinus follows a defined pathway, entering predominantly from anterior and superior sources through the trabeculated dural spaces that characterize its internal architecture. These spaces allow to traverse the sinus laterally to the and its sympathetic plexus. The flow then exits posteriorly via the superior and inferior petrosal sinuses, ultimately directing blood to the or the basilar plexus along the clivus. This pathway integrates the cavernous sinus into the broader dural venous network, enabling efficient collection and transport without direct cardiac involvement. Notably, the cavernous sinus lacks venous valves, permitting potential bidirectional flow that can extend to extracranial networks like the . This valveless structure contributes to the risk of retrograde spread of infections from facial or pharyngeal regions into intracranial spaces. Overall, the cavernous sinus plays a pivotal role in the cranial venous system by integrating into the dural venous drainage pathway, thus supporting hemodynamic balance in the brain and surrounding tissues.

Neurovascular Interactions

The cavernous sinus exemplifies a specialized neurovascular compartment where maintain intimate yet protected relationships with arterial and venous elements, enabling efficient transmission of neural signals while mitigating mechanical interference. III, IV, VI, and branches V1 and V2 course through or adjacent to the sinus, with many embedded within the dural layers that form its walls, allowing for a safeguarded passage amid the surrounding venous and the traversing (ICA). This embedding in the dura provides and , facilitating the nerves' progression toward orbital and targets without direct exposure to fluctuating venous pressures. A key aspect of these interactions involves sympathetic innervation, delivered via the carotid plexus that encases the ICA. Postganglionic sympathetic fibers from the travel along the ICA into the cavernous sinus, where they distribute to ocular structures, including via the ophthalmic division of the () to regulate tone and pupillary dilation. This pathway ensures autonomic control reaches the eye, supporting functions such as in response to sympathetic activation, while the plexus's proximity to the ICA underscores the sinus's role in bundling neural and vascular conduits. The of the ICA exerts subtle hemodynamic influences on nearby , transmitting pressure variations that could modulate neural excitability or mobility within the . Dural partitions and fibrous trabeculae within the sinus play a critical role in organization, segregating venous compartments to avert direct intermixing of blood with neural elements, yet permitting shared venous sheaths that envelop the ICA and (CN VI). This architecture balances separation for protection with communal vascular support, potentially buffering against arterial pulsations and aiding in autonomic , such as sustained pupillary responses.

Clinical Aspects

Pathological Conditions

The cavernous sinus is susceptible to a range of pathological conditions that can lead to venous congestion, , and vascular shunting, often resulting in severe ocular and neurological deficits. These include infectious and noninfectious thromboses, compressive syndromes, fistulas, inflammatory processes, and neoplastic invasions, each with distinct mechanisms involving the sinus's unique neurovascular . Cavernous sinus thrombosis (CST) is a rare but life-threatening condition characterized by formation within the cavernous sinus, which can be septic or aseptic. Septic typically originates from contiguous spread of infection via the valveless facial or ophthalmic veins, often from facial cellulitis, , or orbital infections, leading to purulent material accumulation and propagation of septic emboli. Aseptic , in contrast, arises from non-infectious causes such as hypercoagulable states, , or , resulting in sterile clot formation without an infectious nidus. Common symptoms include severe (reported in 50-90% of cases), periorbital swelling, proptosis, ophthalmoplegia due to cranial nerve involvement (particularly , and ), , and ocular pain from venous congestion; untreated septic carries a high of 80% to 100% due to and cerebral extension. Cavernous sinus manifests as unilateral dysfunction of the traversing the cavernous sinus (, , and ), leading to ophthalmoplegia, ptosis, proptosis, and over the due to compressive or infiltrative lesions. Primary causes include laterally invasive pituitary adenomas, which extend into the sinus and encase the , often graded by the Knosp system (grades 0-4 based on degree of carotid encasement and lateral extension, with grade 3-4 indicating significant invasion). Other etiologies encompass meningiomas arising from the sinus dura, which grow slowly and compress adjacent structures, and metastatic tumors that infiltrate via hematogenous spread, all contributing to progressive nerve palsies and potential Horner from sympathetic fiber involvement. Carotid-cavernous fistula (CCF) involves abnormal arteriovenous shunting between the carotid artery and the cavernous sinus, classified as direct (type A, high-flow) or indirect (types B-D, low-flow). Direct CCFs result from traumatic rupture of the intracavernous carotid wall, often following head injury, creating a direct fistula that causes pulsatile high-pressure flow into the sinus and retrograde drainage into orbital veins. Indirect CCFs occur spontaneously due to dural microvascular ruptures, associated with conditions like hypertension or connective tissue disorders, leading to lower-flow shunting without gross arterial tear. Symptoms arise from orbital venous congestion and include proptosis, chemosis, pulsatile exophthalmos, diplopia, orbital pain, and progressive vision loss from elevated intraocular pressure or ischemia; a classic triad of proptosis, chemosis, and ocular bruit is often present in direct fistulas. Infections and inflammations affecting the cavernous sinus range from granulomatous processes to opportunistic invasions in vulnerable hosts. Tolosa-Hunt syndrome is an idiopathic granulomatous inflammation confined to the cavernous sinus or , causing painful ophthalmoplegia through sterile inflammatory infiltration of the dural walls and nerve sheaths. In immunocompromised patients, fungal infections such as invasive can invade the sinus from adjacent , leading to angioinvasive , , and cranial nerve deficits via hyphal spread and endothelial damage. These processes often present with acute headache, fever, and rapid-onset ophthalmoplegia, mimicking other septic etiologies. Tumors of the cavernous sinus can be primary or secondary, with disrupting venous outflow and compressing neurovascular elements. Primary tumors include cavernous hemangiomas, vascular malformations that present as expansile masses causing gradual proptosis and through . Chordomas, arising from notochordal remnants, exhibit locally aggressive bone erosion and soft tissue into the sinus, leading to cranial nerve palsies and headache. Secondary tumors, such as pituitary adenomas, invade laterally using the Knosp grading to assess extent (e.g., grade 2 involves extension beyond the carotid but without encasement, while grade 4 fully obliterates the sinus space), resulting in hormonal dysregulation alongside compressive symptoms. Meningiomas and metastases further contribute by dural-based growth or hematogenous seeding, respectively, often distorting the sinus laterally and causing insidious neurological decline.

Diagnosis and Imaging

Diagnosis of cavernous sinus abnormalities typically begins with a clinical examination to assess for characteristic neurological deficits. Patients commonly exhibit ophthalmoplegia involving III, IV, and VI, resulting in restricted eye movements such as impaired elevation, depression, adduction, and abduction of the affected eye. Ptosis, proptosis, and may accompany these findings due to venous congestion, while sensory loss in the ophthalmic (V1) and maxillary (V2) distributions of the (CN V) is frequent. can signal elevated from impaired venous drainage. These signs, often unilateral and painful, raise suspicion for cavernous sinus involvement and guide subsequent . Imaging modalities are essential for confirming the and characterizing the underlying . Magnetic resonance imaging (MRI) with gadolinium contrast is the preferred initial study, offering superior soft-tissue resolution to evaluate the cavernous sinus contents, including and vascular structures. T1- and T2-weighted sequences reveal abnormalities such as sinus expansion, while MR (MRV) detects through filling defects or absent flow signals. (CT) serves as an accessible alternative, particularly in emergencies; non-contrast CT may show hyperdensity indicating acute , and contrast-enhanced CT can demonstrate the empty delta sign—a triangular filling defect outlined by enhancing dura—in cavernous sinus . For suspected vascular anomalies like carotid-cavernous fistulas (), CT () identifies abnormal shunts, though MRI often shows characteristic flow voids representing high-velocity arterial flow within the sinus. Specific imaging findings aid in narrowing the etiology. In thrombosis, MRI demonstrates convex lateral wall bulging, heterogeneous signal intensity, and restricted diffusion on diffusion-weighted imaging, often with engorged superior ophthalmic veins. CCF typically appears as asymmetric sinus enlargement with prominent flow voids on T2-weighted MRI and dilated draining veins. Tolosa-Hunt syndrome, an inflammatory condition, manifests as dural thickening and avid enhancement of the cavernous sinus on post-contrast T1-weighted MRI, without mass effect. Tumors may present as enhancing masses encroaching on the sinus, with bone erosion visible on CT. Differential diagnosis relies on the pattern of cranial nerve involvement to distinguish cavernous sinus syndrome from related entities. Orbital apex syndrome additionally affects the (CN II), causing vision loss, whereas superior orbital fissure syndrome spares CN II and VI, limiting deficits to CN III, IV, and V1. Laboratory evaluation supports ; for septic thrombosis, blood cultures identify pathogens in up to 70% of cases, and elevated levels suggest hypercoagulability. In neoplastic cases, of accessible lesions provides histopathological confirmation.

Treatment and Management

Treatment of cavernous sinus thrombosis (CST) primarily involves aggressive intravenous broad-spectrum antibiotics to target common pathogens such as Staphylococcus aureus and Streptococcus species, with regimens typically including vancomycin combined with ceftriaxone or cefotaxime for coverage against methicillin-resistant strains and gram-negative organisms. Anticoagulation with unfractionated heparin or low-molecular-weight heparin is recommended in most cases, even in septic thrombosis, to prevent propagation of the thrombus and reduce complications, provided there are no absolute contraindications like active bleeding; following the acute phase, transition to oral anticoagulation with vitamin K antagonists or direct oral anticoagulants (DOACs) is standard, with DOACs showing comparable efficacy and safety per 2024 guidelines. Management of complications such as sepsis requires supportive measures including fluid resuscitation, vasopressors if needed, and surgical drainage of the primary infection source, such as sinusitis via sphenoidectomy or ethmoidectomy. With early antibiotic therapy, CST mortality has decreased from nearly 100% in the pre-antibiotic era to less than 20-30%. For carotid-cavernous fistulas (), endovascular is the first-line treatment, particularly for high-flow direct fistulas, involving transarterial or transvenous placement to deploy detachable coils, balloons, or liquid embolic agents like n-butyl cyanoacrylate to occlude the abnormal arteriovenous shunt. Low-flow indirect CCFs may be managed conservatively with observation, as spontaneous resolution occurs in up to 20-50% of cases, especially if symptoms are mild. Tumors invading the cavernous sinus, such as pituitary adenomas, are often addressed via transsphenoidal endoscopic surgery, where the extent of resection is guided by Knosp grading to assess invasion severity—grades 0-2 typically allow gross total resection, while higher grades may necessitate subtotal removal to preserve cranial nerve function. For cavernous sinus meningiomas, stereotactic , such as Gamma Knife, provides effective long-term tumor control with tumor growth arrest in over 90% of cases and low complication rates. Metastatic lesions in the cavernous sinus are generally palliated with systemic tailored to the type, often combined with radiotherapy for symptom relief. Inflammatory conditions like Tolosa-Hunt syndrome respond rapidly to high-dose corticosteroids, such as oral at 60-80 mg daily, leading to symptom resolution within 72 hours in most patients; recurrent cases may require steroid-sparing immunosuppressants like or . Supportive care across cavernous sinus disorders includes a multidisciplinary approach involving neurosurgeons, ophthalmologists, and otolaryngologists to address complications like proptosis, for which orbital decompression surgery may be performed to alleviate compression and preserve vision. Early intervention in all these conditions improves outcomes, emphasizing prompt diagnosis and coordinated care.

References

  1. [1]
    Neuroanatomy, Cavernous Sinus - StatPearls - NCBI Bookshelf
    The cavernous sinus is part of the brain's dural venous sinus and contains multiple neuro-vasculatures. It is situated bilaterally to the sella turcica.Introduction · Structure and Function · Nerves · Surgical Considerations
  2. [2]
    Venous Anatomy of the Cavernous Sinus and Relevant Veins - PMC
    This sinus plays a role as a crossroad receiving venous blood flow from the facial, orbital, meningeal, and neural venous tributaries.
  3. [3]
    Cavernous sinus: anatomy, location, contents, drainage | Kenhub
    The cavernous sinuses are 1 cm wide cavities that extend a distance of 2 cm from the most posterior aspect of the orbit to the petrous part of the temporal bone ...
  4. [4]
    Microsurgical Anatomy of the Cavernous Sinus
    The roof of the cavernous sinus is formed by the upward extension of the lateral wall as it joins with the thickened tentorial edge attached to both the ...
  5. [5]
    The Cavernous Sinus - Contents - Borders - TeachMeAnatomy
    The cavernous sinuses are located within the middle cranial fossa, on either side of the sella turcica of the sphenoid bone (which contains the pituitary gland) ...
  6. [6]
    Anatomy of the cavernous sinus in - Journal of Neurosurgery
    The cavernous sinuses are located on each side of the sphenoid sinus, sella, and pituitary gland. They extend from the superior orbital fissure in front to the ...
  7. [7]
    The cavernous sinus: An anatomic study with clinical implication
    Mar 23, 2024 · The cavernous sinus is a tripartite venous osteomeningeal compartment intimately neighboring vital structures including the optic tracts, ...
  8. [8]
    Cavernous Sinus Anatomy - EBM Consult
    Internal carotid arteries & its small branches · Carotid plexus of sympathetic nerve · Abducens nerve (CN VI) · Maxillary nerve (CN V2) · Oculomotor nerve (CN III) ...<|control11|><|separator|>
  9. [9]
    Cavernous Sinus Syndrome - EyeWiki
    ... (cranial nerve (CN) III, IV, VI), autonomic dysfunction (Horner syndrome) or sensory CN V1- CN V2 loss. Anatomy. The venous drainage system of the head and ...
  10. [10]
    Meningohypophyseal Trunk - Neuroangio.org
    Meningohypophyseal Trunk (number 2 above) is a key region located in the posterior genu of the ICA cavernous segment. It may be a single or several trunks. MHT ...
  11. [11]
    Dural Venous System in the Cavernous Sinus - PubMed Central - NIH
    Apr 11, 2016 · The cranial dural sinuses are venous channels situated between the two layers of dura matter that carry venous drainage from the brain.
  12. [12]
    Cavernous sinus hemodynamic buffering model (CSHBM): a novel ...
    Oct 7, 2025 · This buffering function could protect adjacent cranial nerves from pulsatile ... internal carotid artery and protecting adjacent cranial nerves.
  13. [13]
    Cavernous Sinus Thrombosis - StatPearls - NCBI Bookshelf
    Jun 16, 2025 · Patients with cavernous sinus thrombosis most commonly complain of fever, headache in 50% to 90% of patients, periorbital swelling, ocular pain, ...Etiology · Epidemiology · Pathophysiology · Treatment / Management
  14. [14]
    A case of aseptic bilateral cavernous sinus thrombosis following a ...
    This case report aims to describe the first report of bilateral aseptic cavernous sinus thrombosis (CST) with a recent history of severe acute respiratory ...
  15. [15]
    Transorbital superior ophthalmic vein sacrifice to preserve vision in ...
    Oct 29, 2014 · Symptoms of CST, both septic and aseptic, generally derive from cranial nerve and meningeal irritation. Headache is very common, reported in up ...
  16. [16]
    Cavernous Sinus Syndromes - StatPearls - NCBI Bookshelf - NIH
    Jul 17, 2023 · Cavernous sinus syndrome (CSS) is any disease process that affects the cavernous sinus. It presents as proptosis, chemosis, ophthalmoplegia, Horner syndrome or ...
  17. [17]
    Cavernous Sinus Involvement by Pituitary Adenomas - NIH
    Jan 23, 2017 · The most common presenting symptoms included hormonal imbalances in 37% and headaches in 26% of the cases. Macroadenomas represented 77% of the ...
  18. [18]
    Evidence-based treatment of cavernous sinus meningioma - NIH
    Nov 22, 2019 · Cavernous sinus meningioma (CSM) causes gradual ophthalmoplegia and may eventually cause compression of the chiasma. The tumor is often ...Missing: syndrome | Show results with:syndrome
  19. [19]
    Carotid Cavernous Fistula - StatPearls - NCBI Bookshelf
    Apr 3, 2023 · The classical triad[4] of proptosis, ocular bruit, and chemosis are common, but symptoms such as visual disturbances, orbital pain, and cranial ...
  20. [20]
    Indirect carotid-cavernous fistula following minor head trauma ... - NIH
    Sep 24, 2012 · Indirect carotid-cavernous fistulas often present with subtle symptoms rather than the dramatic symptoms typically associated with carotid ...
  21. [21]
    Carotid-Cavernous Fistula: A Rare but Treatable Cause of Rapidly ...
    Carotid cavernous fistulas (CCFs) are a rare but potentially devastating cause of orbital symptoms, visual loss and periocular disfigurement. CCF patients ...
  22. [22]
    A case report on recurrent alternating Tolosa-Hunt syndrome due to ...
    Jan 17, 2023 · Tolosa-Hunt syndrome (THS) is characterized by painful ophthalmoplegia caused by idiopathic granulomatous inflammation involving the cavernous sinus region.Missing: immunocompromised | Show results with:immunocompromised
  23. [23]
    Invasive Aspergillosis with Cavernous Sinus Thrombosis Following ...
    Nov 13, 2024 · Invasive aspergillosis is a rare but severe fungal infection primarily affecting immunocompromised individuals. The Coronavirus Disease-2019 ...
  24. [24]
    Orbital Fungal Infection: Complex Case Exhibits Keys to Diagnosis ...
    Dec 10, 2021 · ... infectious, vascular and neoplastic etiologies must be considered. Tolosa-Hunt syndrome is a common inflammatory cause of orbital apex syndrome.
  25. [25]
    Diseases of the Sella Turcica and Parasellar Region - NCBI - NIH
    Feb 11, 2024 · Cavernous hemangiomas are acquired lesions and not true malformations and rarely may occur in the suprasellar cistern.
  26. [26]
    Blood Supply of Cranial Nerves Passing Through the Cavernous ...
    Oct 8, 2021 · However, many tumors can arise in or invade the CS, these include trigeminal schwannomas, pituitary adenomas, chordomas and chondrosarcomas.
  27. [27]
    Endoscopic endonasal surgery for nonadenomatous, nonmeningeal ...
    Apr 29, 2016 · Pituitary adenomas and meningiomas were excluded. Degree of invasion of the CS was classified using the Knosp-Steiner (KS) grading system as ...
  28. [28]
    Imaging Lesions of the Cavernous Sinus - PMC - PubMed Central
    Pituitary adenomas may grow laterally and invade the CS. A sign of CS invasion is encasement of the intracavernous ICA by >30% of its diameter or tumor ...<|separator|>
  29. [29]
    Cavernous Sinus Syndrome - EyeWiki
    ### Summary of Neural Elements in Cavernous Sinus (Anatomy Section)
  30. [30]
  31. [31]
  32. [32]
    Empty delta sign (dural venous sinus thrombosis) - Radiopaedia.org
    Nov 29, 2024 · The empty delta sign is a CT sign of dural venous sinus thrombosis of the superior sagittal sinus, where contrast outlines a triangular filling defect.
  33. [33]
    Carotid Cavernous Fistula - EyeWiki
    Oct 6, 2025 · MRI: Compared to CT, MRI can better demonstrate fat stranding reflecting orbital edema and abnormal flow voids. Although noninvasive ...
  34. [34]
    Cavernous Sinus Thrombosis Medication - Medscape Reference
    Sep 2, 2025 · Antibiotics. Ceftriaxone (Rocephin (DSC)) · View full drug information ... Vancomycin (Firvanq, Vancocin) · View full drug information.
  35. [35]
    Septic cavernous sinus thrombosis - UpToDate
    Apr 29, 2024 · Antibiotics · Anticoagulation · Surgery · Lack of role for glucocorticoids.
  36. [36]
    Cavernous Sinus Thrombosis: Background, Etiology, Pathophysiology
    Sep 2, 2025 · With aggressive management, including antibiotics and, when indicated, surgical drainage, the mortality rate is now less than 30%. Morbidity ...
  37. [37]
    Endovascular treatment of carotid cavernous sinus fistula - NIH
    Embolization can be achieved with detachable platinum coils, silk and liquid embolic agents such as n-butyl cyanoacrylate (n-BCA), and ethylene-vinyl alcohol ...
  38. [38]
    Endovascular transvenous treatment of carotid–cavernous fistula
    Aug 14, 2024 · The mainstay of therapy for carotid–cavernous fistulas consists of transarterial or transvenous embolization, while other treatment options ...
  39. [39]
    Carotid-Cavernous Fistula: Practice Essentials, Prognosis
    Jan 22, 2021 · Direct CCFs are high-flow fistulas with a direct connection between the internal carotid artery (ICA) and the cavernous sinus. Dural CCFs are ...<|control11|><|separator|>
  40. [40]
    Therapeutic Strategy for Cavernous Sinus-Invading Non ... - NIH
    A grading system proposed by Knosp et al. [8] for evaluating parasellar extension of the tumor has been widely used to evaluate carvernous sinus invasion (CSI) ...
  41. [41]
    Invasion of the cavernous sinus space in pituitary adenomas - PubMed
    The proposed classification proved that with increasing grades, the likelihood of surgically observed invasion rises and the chance of GTR and ER decreases.
  42. [42]
    Gamma Knife stereotactic radiosurgery for cavernous sinus ...
    Jul 20, 2018 · This long-term study showed that Gamma Knife radiosurgery provided long-term tumor control for most patients with CSM.
  43. [43]
    Stereotactic Radiosurgery for Benign Cavernous Sinus Meningiomas
    Aug 22, 2022 · We believe SRS is a valuable treatment option for CSM, both as a primary treatment, and as an adjunct following surgery. Imaging diagnosis is ...
  44. [44]
    Cavernous Sinus Metastasis in Patients of Head & Neck Squamous ...
    Apr 16, 2024 · Typically, the treatment of cavernous sinus metastasis involves radiotherapy and chemotherapy with a palliative intent. Unfortunately, the ...
  45. [45]
    Tolosa-Hunt Syndrome - StatPearls - NCBI Bookshelf - NIH
    Unlike typical headaches, patients with Tolosa-Hunt syndrome are treated with steroids and immunosuppressive agents. Despite treatment, recurrences are common, ...Continuing Education Activity · Introduction · Evaluation · Treatment / Management
  46. [46]
    Tolosa-Hunt Syndrome - EyeWiki
    Tolosa–Hunt Syndrome (THS) is a rare, idiopathic granulomatous inflammatory disorder involving the cavernous sinus, superior orbital fissure, ...
  47. [47]
    Orbital Decompression - EyeWiki
    Orbital decompression is a surgical procedure that is used to treat exophthalmos (also known as proptosis), a condition in which the eye protrudes ...Background · Differential Diagnosis · Thyroid Eye Disease · Indications for Orbital...